Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Temozolomide +/- Interferon-alpha in High-grade Gliomas
NCT01765088Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2012
- Primary completion
- Dec 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa in glioma, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01765088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765088.